ByrneRA,SarafoffN,KastratiA,SchomigA, 2009.Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment,Drug Saf 32 749 -70
De LucaG,DirksenMT,SpauldingC, 2012.Drug-eluting vs baremetal stents in primary angioplasty: a pooled patient-level metaanalysis of randomized trials,Arch Intern Med 172 611 -21
StoneGW,EllisSG,CoxDA, 2004.A polymer-based, paclitaxeleluting stent in patients with coronary artery disease,N Engl J Med 350 221 -31
ByrneRA,JonerM,KastratiA, 2009.Polymer coatings and delayed arterial healing following drug-eluting stent implantation,Minerva Cardioangiol 57 567 -84
FinnAV,NakazawaG,KolodgieFD,VirmaniR, 2009.Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing?,JACC Cardiovasc Interv 2 300 -2
FinnAV,NakazawaG,JonerM., 2007.Vascular responses to drug eluting stents: importance of delayed healing,Arterioscler Thromb Vasc Biol 27 1500 -10
KastratiA,MehilliJ,PacheJ, 2007.Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents,N Engl J Med 356 1030 -9
MorenoR,FernandezC,HernandezR, 2005.Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies,J Am Coll Cardiol 45 954 -9
WesselyR,SchomigA,KastratiA, 2006.Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different,J Am Coll Cardiol 47 708 -14
KastratiA,MehilliJ,von BeckerathN., 2005.Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial,JAMA 293 165 -71
MehilliJ,DibraA,KastratiA, 2006.Randomized trial of paclitaxeland sirolimus-eluting stents in small coronary vessels,Eur Heart J 27 260 -6
QianJ,ChenZ,MaJ,GeJ, 2012.Sirolimus- versus paclitaxel-eluting stents for coronary bifurcations intervention: a meta-analysis of five clinical trials,Catheter Cardiovasc Interv 80 507 -13
ZhangF,DongL,GeJ, 2010.Meta-analysis of five randomized clinical trials comparing sirolimus- versus paclitaxel-eluting stents in patients with diabetes mellitus,Am J Cardiol 105 64 -8
SchomigA,DibraA,WindeckerS., 2007.A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxeleluting stents in patients with coronary artery disease,J Am Coll Cardiol 50 1373 -80
StiermaierT,HeinzA,SchlomaD, 2014.Five-year clinical follow-up of a randomized comparison of a polymer-free sirolimuseluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus (LIPSIA Yukon trial),Catheter Cardiovasc Interv 83 418 -24
OtsukaM,YokoiH,MatsuyamaY., 2014.Comparison of sirolimusand paclitaxel-eluting stents in patients with moderate renal insufficiency: results from the J-DESsERT trial,Cardiovasc Revasc Med 15 323 -8
BligaardN,ThuesenL,SaunamäkiK., 2014.Similar five-year outcome with paclitaxel- and sirolimus-eluting coronary stents,Scand Cardiovasc J 48 148 -55
ZhangY,ShenJ,LiZ, 2013.Two-year clinical outcomes of different drug-eluting stents with different polymer coating strategies in coronary artery heart disease: A multi-centre, randomised, controlled clinical trial,Int J Cardiol 168 2646 -52
KingL,ByrneRA,MehilliJ,SchömigA,KastratiA,PacheJ, 2013.Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: final results of the intracoronary stenting and angiographic restenosis - test equivalence between two drug-eluting stents (ISAR-TEST) trial,Catheter Cardiovasc Interv 81 E23 -28
JangSJ,ParkDW,KimWJ, 2013.Differential long-term outcomes of zotarolimus-eluting stents compared with sirolimus-eluting and paclitaxel-eluting stents in diabetic and nondiabetic patients: two-year subgroup analysis of the ZEST randomized trial,Catheter Cardiovasc Interv 81 1106 -14
GurmHS,BoydenT,WelchKB, 2008.Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: a meta-analysis,Am Heart J 155 630 -9
ZhangX,XieJ,LiG,ChenQ,XuB, 2014.Head-to-head comparison of sirolimus-eluting stents versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of 76 studies,PLoS One 9 e97934 -
NasuK,OikawaY,Yoshikawa R, 2013.A randomized comparison of sirolimus- vs. paclitaxel-eluting stents for treatment of bifurcation lesions by single stent and kissing balloon: results of the SINGLE KISS trial,Int J Cardiol 166 187 -92
AbizaidA,OrmistonJA,FajadetJ, 2013.Two-year follow-up of the NEVO Res Elution-I(NEVO RES-I) trial: A randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions,EuroIntervention 9 721 -9
PattersonC,MaperaS,LiHH, 2006.Comparative effects of paclitaxel and rapamycin on smooth muscle migration and survival: role of AKT-dependent signaling,Arterioscler Thromb Vasc Biol 26 1473 -80
SmithEJ,RothmanMT, 2003.Antiproliferative coatings for the treatment of coronary heart disease: what are the targets and which are the tools,J Interv Cardiol 16 475 -83
RogersCD, 2005.Drug-eluting stents: clinical perspectives on drug and design differences,Rev Cardiovasc Med 6 S3 -12
KastratiA,DibraA,EberleS, 2005.Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials,JAMA 294 819 -25
LeeSW,ParkSW,KimYH, 2011.A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial,Cardiovasc Interv 4 310 -16
KamoiD,IshiiH,Takahashi H. Sirolimus, 2013.- vs. paclitaxel-eluting stent to coronary intervention in dialysis patients,Int J Cardiol 165 533 -6
KimYH,ParkSW,Lee SW, 2006.Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease,Circulation 114 2148 -53
NakazawaG,FinnAV,JonerM., 2008.Delayed arterial healing and increased late stent thrombosis at culprit sites after drugeluting stent placement for acute myocardial infarction patients: an autopsy study,Circulation 118 1138 -45
KukrejaN,OnumaY,Garcia-GarciaH,DaemenJ,van DomburgR,SerruysPW, .Primary percutaneous coronary, -
BrodieB,PokharelY,FleishmanN., 2011.Very late stent thrombosis after primary percutaneous coronary intervention with baremetal and drug-eluting stents for ST-segment elevation myocardial infarction: a 15-year single-center experience,JACC Cardiovasc Interv 4 30 -8
ByrneRA,IijimaR,MehilliJ, 2009.Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer,JACC Cardiovasc Interv 2 291 -9
WallaceEL,Abdel-LatifA,CharnigoR, 2012.Meta-analysis of longterm outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for STsegment elevation myocardial infarction,Am J Cardiol 109 932 -40